Akebia Therapeutics | AKBA - Loan Capital


Akebia Therapeutics reported $36.39M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Ardelyx USD 203.52M 683K Mar/2026
Astellas Pharma JPY 320B 0 Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Celltrion KRW 411.27B 998.23M Mar/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 37.53B 1.91B Mar/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 603M 7M Mar/2026
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Organigram Holdings CAD 60.76M 1.77M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 33.16M 3.52M Mar/2026
Prothena USD 0 0 Dec/2024
PTC Therapeutics USD 286.94M 1.74B Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 17K 26K Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026